Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$16.75 - $48.98 $50,250 - $146,940
3,000 New
3,000 $5,000
Q1 2023

May 01, 2023

SELL
$37.27 - $46.57 $55,905 - $69,855
-1,500 Reduced 88.24%
200 $0
Q4 2022

Feb 07, 2023

SELL
$32.2 - $43.61 $38,640 - $52,332
-1,200 Reduced 41.38%
1,700 $0
Q3 2022

Oct 25, 2022

SELL
$32.28 - $43.27 $48,420 - $64,905
-1,500 Reduced 34.09%
2,900 $5,000
Q2 2022

Aug 04, 2022

BUY
$27.52 - $37.99 $68,800 - $94,975
2,500 Added 131.58%
4,400 $5,000
Q1 2022

Apr 14, 2022

SELL
$30.71 - $45.71 $442,224 - $658,224
-14,400 Reduced 88.34%
1,900 $1,000
Q4 2021

Jan 18, 2022

BUY
$37.06 - $47.11 $541,076 - $687,806
14,600 Added 858.82%
16,300 $0
Q3 2021

Oct 26, 2021

SELL
$40.26 - $57.37 $148,962 - $212,269
-3,700 Reduced 68.52%
1,700 $1,000
Q2 2021

Jul 19, 2021

BUY
$54.88 - $79.29 $71,344 - $103,077
1,300 Added 31.71%
5,400 $6,000
Q1 2021

Apr 26, 2021

SELL
$70.65 - $96.76 $70,650 - $96,760
-1,000 Reduced 19.61%
4,100 $39,000
Q4 2020

Jan 21, 2021

BUY
$58.41 - $89.06 $40,887 - $62,342
700 Added 15.91%
5,100 $101,000
Q3 2020

Oct 27, 2020

SELL
$41.13 - $62.45 $16,452 - $24,980
-400 Reduced 8.33%
4,400 $34,000
Q2 2020

Jul 22, 2020

BUY
$25.95 - $43.15 $121,965 - $202,805
4,700 Added 4700.0%
4,800 $8,000
Q1 2020

May 07, 2020

SELL
$26.15 - $77.24 $721,740 - $2.13 Million
-27,600 Reduced 99.64%
100 $0
Q4 2019

Feb 06, 2020

BUY
$60.18 - $154.77 $974,916 - $2.51 Million
16,200 Added 140.87%
27,700 $45,000
Q3 2019

Oct 28, 2019

BUY
$140.29 - $189.96 $701,450 - $949,800
5,000 Added 76.92%
11,500 $77,000
Q2 2019

Aug 09, 2019

SELL
$157.85 - $183.09 $4.7 Million - $5.46 Million
-29,800 Reduced 82.09%
6,500 $187,000
Q1 2019

May 10, 2019

BUY
$89.33 - $163.65 $1.12 Million - $2.05 Million
12,500 Added 52.52%
36,300 $481,000
Q4 2018

Feb 05, 2019

BUY
$81.94 - $139.71 $1.29 Million - $2.19 Million
15,700 Added 193.83%
23,800 $153,000
Q3 2018

Nov 07, 2018

BUY
$138.11 - $169.04 $179,543 - $219,752
1,300 Added 19.12%
8,100 $149,000
Q2 2018

Aug 10, 2018

SELL
$140.36 - $175.76 $238,612 - $298,792
-1,700 Reduced 20.0%
6,800 $144,000
Q1 2018

May 11, 2018

SELL
$152.15 - $192.33 $7.82 Million - $9.89 Million
-51,400 Reduced 85.81%
8,500 $202,000
Q4 2017

Jan 17, 2018

SELL
$60.72 - $167.34 $637,560 - $1.76 Million
-10,500 Reduced 14.91%
59,900 $3.97 Million
Q3 2017

Oct 17, 2017

BUY
$61.4 - $88.52 $4.32 Million - $6.23 Million
70,400
70,400 $411,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.